Search results
Diagnosing Psoriatic Arthritis for the Dermatologist
Medscape· 1 week agoEditor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 week agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque psoriasis ...
Galapagos (NASDAQ:GLPG) Reaches New 52-Week Low at $29.45
ETF DAILY NEWS· 1 week agoShares of Galapagos NV (NASDAQ:GLPG – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $29.45 and last traded at $29.49, with a volume of 16106 shares. The ...
Bristol-Myers Squibb (NYSE:BMY) Short Interest Down 5.7% in March
ETF DAILY NEWS· 1 week agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 35,120,000 shares, a decline of 5.7% ...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 7 days agoRinvoq is already approved to treat several autoimmune diseases like rheumatoid arthritis, psoriatic...
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...
NBC 17 Raleigh· 1 week ago− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen ...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 2 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Death After Hemorrhoid Cream; Working Late and Illness; Full-Blown Hoarding
MedPage Today· 1 week agoA California woman died of lead poisoning associated with use of castor oil hemorrhoid ointment...
William Blair Comments on Amgen Inc.’s Q1 2024 Earnings (NASDAQ:AMGN)
ETF DAILY NEWS· 1 week agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at William Blair reduced their Q1 2024 earnings per share (EPS) estimates for Amgen in a research note issued on Wednesday, April ...
Johnson & Johnson (NYSE:JNJ) Stock Holdings Lowered by Schmidt P J Investment Management Inc.
ETF DAILY NEWS· 1 week agoSchmidt P J Investment Management Inc. decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.2% during the 4th quarter, according to the company in its most recent disclosure ...